Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Francesca Zazzeroni

Department of Biotechnological and Applied Clinical Sciences, University of L’Aq...

Share Link

Share

Information

Francesca Zazzeroni graduated in Biological Sciences at the University of L’Aquila, Italy in 1994, and obtained a PhD in Experimental Medicine at the University of L’Aquila, Italy in 1999. She worked as a research associate at the Ben May Institute for Cancer Research, University of Chicago, Chicago, IL, USA from 1999 to 2003. She is currently a full professor of Medical and Biotechnology Laboratory Techniques at the University of L’Aquila, Italy. The focus of her research has been the understanding of the mechanisms through which NF-κB drives oncogenesis by integrating the signaling networks governing cancer-cell survival and TME-based inflammation, and the cancer-selective targeting of the NF-κB effectors as a novel therapeutic intervention. She was awarded the Fellowship “Leonino Fontana e Maria Lionello” for Cancer Research, Fondazione Italiana per la Ricerca sul Cancro (FIRC) (1999), and the “AICC Prize for Senior Investigators” (2008).

Research Keywords & Expertise

Apoptosis
Inflammation
microRNA
Preclinical models
Cancer molecular patho...

Fingerprints

22%
Apoptosis
17%
Inflammation
13%
microRNA

Short Biography

Francesca Zazzeroni graduated in Biological Sciences at the University of L’Aquila, Italy in 1994, and obtained a PhD in Experimental Medicine at the University of L’Aquila, Italy in 1999. She worked as a research associate at the Ben May Institute for Cancer Research, University of Chicago, Chicago, IL, USA from 1999 to 2003. She is currently a full professor of Medical and Biotechnology Laboratory Techniques at the University of L’Aquila, Italy. The focus of her research has been the understanding of the mechanisms through which NF-κB drives oncogenesis by integrating the signaling networks governing cancer-cell survival and TME-based inflammation, and the cancer-selective targeting of the NF-κB effectors as a novel therapeutic intervention. She was awarded the Fellowship “Leonino Fontana e Maria Lionello” for Cancer Research, Fondazione Italiana per la Ricerca sul Cancro (FIRC) (1999), and the “AICC Prize for Senior Investigators” (2008).